These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26674753)

  • 1. Prediction of Ocular Drug Distribution from Systemic Blood Circulation.
    Vellonen KS; Soini EM; Del Amo EM; Urtti A
    Mol Pharm; 2016 Sep; 13(9):2906-11. PubMed ID: 26674753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Modeling of Ocular Pharmacokinetics and Adverse Effects.
    Ghemtio L; Xhaard H; Urtti A; Kidron H
    Curr Pharm Des; 2016; 22(46):6928-6934. PubMed ID: 27669964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.
    del Amo EM; Vellonen KS; Kidron H; Urtti A
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):215-26. PubMed ID: 25603198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
    Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the African green monkey as a preclinical model for ocular pharmacokinetic studies.
    Glogowski S; Ward KW; Lawrence MS; Goody RJ; Proksch JW
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):290-8. PubMed ID: 22235843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit as an animal model for intravitreal pharmacokinetics: Clinical predictability and quality of the published data.
    Del Amo EM; Urtti A
    Exp Eye Res; 2015 Aug; 137():111-24. PubMed ID: 25975234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies.
    Fuchs H; Igney F
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):115-122. PubMed ID: 28055308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic pharmacokinetic/pharmacodynamic model of factor D inhibition in cynomolgus monkeys by lampalizumab for the treatment of geographic atrophy.
    Le KN; Gibiansky L; Good J; Davancaze T; van Lookeren Campagne M; Loyet KM; Morimoto A; Jin J; Damico-Beyer LA; Hanley WD
    J Pharmacol Exp Ther; 2015 Nov; 355(2):288-96. PubMed ID: 26359312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacokinetic model for ocular drug delivery.
    Tojo K
    Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1290-4. PubMed ID: 15516748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based ocular pharmacokinetic modeling using computational methods.
    Missel PJ; Sarangapani R
    Drug Discov Today; 2019 Aug; 24(8):1551-1563. PubMed ID: 31319151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of aesculin in rabbit plasma and ocular tissues by high performance liquid chromatography using fluorescent detection: application to a pharmacokinetic study.
    Chen Q; Zeng Y; Kuang J; Li Y; Li X; Zheng Y; Hou H; Hou S
    J Pharm Biomed Anal; 2011 Apr; 55(1):161-7. PubMed ID: 21295934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
    Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
    J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S; Bezwada P; Takanaga H; Hosoi K; Tsuboi T; Ueda K; Kawazu K; Ali Y; Naor J
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):507-14. PubMed ID: 22662868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program.
    Drusano GL; Liu W; Perkins R; Madu A; Madu C; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1683-7. PubMed ID: 7486900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown.
    Shen J; Durairaj C; Lin T; Liu Y; Burke J
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1056-66. PubMed ID: 24448267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
    Ranta VP; Urtti A
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.